Japanese ADNI Project
Japanese ADNI project January 2011, PI Takeshi Iwatsubo, Univ. Tokyo Background: In view of the upcoming clinical trials of disease-modifying drugs for Alzheimer’s disease (AD), there is a compelling need for the establishment of a complete set of surrogate biomarkers that reflect and predict the progression of AD, especially conversion from mild cognitive impairment (MCI) to AD. For this purpose
Effectiveness of systematic treatment selection for psychodynamic and cognitive-behavioural therapy: randomised controlled trial in routine mental healthcare -- Watzke et al. 197 (2): 96 -- The British Journal of Psychiatry
19th August 2024: digital purchasing is currently unavailable on Cambridge Core. Due to recent technical disruption affecting our publishing operation, we are experiencing some delays to publication. We are working hard to restore services as soon as possible and apologise for the inconvenience. For further updates please visit our website: https://www.cambridge.org/universitypress/about-us/news-a
1
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
